WallStreetZenWallStreetZen

NASDAQ: AVXL
Anavex Life Sciences Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Anavex Life Sciences earnings were -$47.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest AVXL earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$11.2M, down 7.6% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, AVXL reported annual earnings of -$43.0M, with -9.5% growth.

AVXL earnings history

Current Revenue
$0.0
Current Earnings
-$47.1M
Current Profit Margin
0%

AVXL Return on Equity

Current Company
-40.9%
Current Industry
-60.2%
Current Market
31.5%
AVXL's Return on Equity (-40.9%)... subscribe to Premium to read more.
High Return on Equity Performance

AVXL undefined

Current Company
-36.4%
Current Industry
-2.5%
AVXL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AVXL announces earnings.

AVXL undefined

Current Company
-47.45%
Current Industry
5.8%
AVXL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AVXL vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AVXL-$47.33M-$47.14MN/A-$0.55
ANAB-$138.18M-$140.62MN/A-$4.79
ORIC-$131.71M-$132.86MN/A-$1.87
ABUS-$75.10M-$76.57MN/A-$0.41
DAWN-$59.13M-$69.08MN/A-$0.71
View Top Biotech Stocks

Anavex Life Sciences Earnings Reports & History FAQ

What were Anavex Life Sciences's earnings last quarter?

On AVXL's earnings call on Invalid Date, Anavex Life Sciences (NASDAQ: AVXL) reported Q1 2025 earnings per share (EPS) of -$0.13, up 0% year over year. Total AVXL earnings for the quarter were -$11.20 million. In the same quarter last year, Anavex Life Sciences's earnings per share (EPS) was -$0.13.

If you're new to stock investing, here's how to buy Anavex Life Sciences stock.

Is Anavex Life Sciences profitable or losing money?

As of the last Anavex Life Sciences earnings report, Anavex Life Sciences is currently losing money. Anavex Life Sciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$47.14 million, a 16.13% increase year over year.

What was AVXL's earnings growth in the past year?

As of Anavex Life Sciences's earnings date in Invalid Date, Anavex Life Sciences's earnings has grown year over year. AVXL earnings in the past year totalled -$47.14 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.